Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication).

Kwok, M K; Leung, G M; Xu, L; Tse, H F; Lam, T H; So, T H; Schooling, C M

Kwok, M K; Leung, G M; Xu, L; Tse, H F; Lam, T H; So, T H; Schooling, C M.

Afiliación

Kwok MK; School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
Leung GM; School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
Xu L; School of Public Health, Sun Yat-sen University, Guangzhou, China.
Tse HF; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR, China.
Lam TH; School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
So TH; Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR, China.
Schooling CM; School of Public Health, The University of Hong Kong, Hong Kong SAR, China.

Hong Kong Med J ; 29 Suppl 4(4): 18-21, 2023 08.

Article en En | MEDLINE | ID: mdl-37690802

Asunto(s)

Enfermedades Cardiovasculares; Humanos; Enfermedades Cardiovasculares/prevención & control; Estudios Cruzados; Suplementos Dietéticos

Buscar en Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Buscar en Google

Imprimir

XML

PubMed Links